Beroctocog alfa - GC Biopharma
Alternative Names: GC 1101; GC 1101C; GC1101 D; GreenGene F; r-FVIII - GC Biopharma; Recombinant factor VIII - GC BiopharmaLatest Information Update: 01 Apr 2022
At a glance
- Originator Green Cross
- Developer GC Biopharma
- Class Antihaemorrhagics; Blood coagulation factors; Recombinant proteins
- Mechanism of Action Blood coagulation factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Haemophilia A
Highest Development Phases
- Marketed Haemophilia A